Search

Search Constraints

You searched for: Author/Creator Guillemet, Cécile

Search Results

1. 2022-RA-783-ESGO Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma. (20th October 2022)

2. Adjustment of young women with breast cancer after chemotherapy: A mediation model of emotional competence via emotional distress. Issue 5 (10th January 2022)

3. Comparison of Response Evaluation Criteria in Solid Tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: A retrospective analysis. Issue 2 (January 2015)

4. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial. Issue 8 (August 2022)

5. Emotional distress and subjective impact of the disease in young women with breast cancer and their spouses. (December 2017)

6. Ewing‐like sarcomas with BCOR‐CCNB3 fusion transcript: A clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant. Issue 12 (31st August 2014)

7. Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France. (May 2016)

8. Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer. (February 2020)

9. Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 12 (December 2016)

10. Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer. Issue 10 (11th June 2015)